Associate Scientist 1/2
AbbVie
Associate Scientist 1/2
AbbVie
Global biopharmaceutical company developing medicines
We are seeking a highly motivated in vivo Scientist who will make contributions to the design, execution, and communication of novel multi-disciplinary research in a highly collaborative Migraine and Pain drug discovery program. Primary responsibilities of the successful candidate will be to conduct basic science studies for the pharmacological evaluation of novel compounds and biologics, as well as to assist in the development of approaches for target engagement and translational biomarkers. He/She will also contribute to the development of new animal models of human disease and will generate high-quality data reports to support the identification and development of novel therapeutics.
Key Responsibilities Include:
Key Competencies:
Applicable only to applicants applying to a position in any location with pay disclosure requirements under state or local law:
Note: No amount of pay is considered to be wages or compensation until such amount is earned, vested, and determinable. The amount and availability of any bonus, commission, incentive, benefits, or any other form of compensation and benefits that are allocable to a particular employee remains in the Company's sole and absolute discretion unless and until paid and may be modified at the Company’s sole and absolute discretion, consistent with applicable law.
AbbVie is an equal opportunity employer and is committed to operating with integrity, driving innovation, transforming lives and serving our community. Equal Opportunity Employer/Veterans/Disabled.
US & Puerto Rico only - to learn more, visit https://www.abbvie.com/join-us/equal-employment-opportunity-employer.html
US & Puerto Rico applicants seeking a reasonable accommodation, click here to learn more:
https://www.abbvie.com/join-us/reasonable-accommodations.html
Compensation: 58656 to 110500 (USD) (YEARLY)
AbbVie is a global biopharmaceutical company that develops and sells medicines to treat serious health conditions. Its portfolio spans immunology, oncology, virology, neuroscience, and aesthetics, with products designed to modulate the immune system, target disease pathways, or support medical aesthetics. AbbVie compounds its products through a heavy emphasis on research and development, investing billions to build a steady pipeline of new therapies. Its medicines are brought to market by selling to healthcare providers, hospitals, and clinics, and in some cases directly to patients via prescriptions. The company differentiates itself through a wide, globally distributed product line, substantial R&D investment, and a commitment to sustainability and patient care, including science-based targets. AbbVie’s goal is to improve patient outcomes by delivering effective treatments for unmet medical needs while pursuing long-term, responsible growth across healthcare markets.
Explore more opportunities at AbbVie